Listed

Nurix Therapeutics, Inc.: Form 10-K for the period ended Nov 30, 2020

Filed with the SEC on Feb 16, 2021 and accepted by EDGAR at Feb 16, 2021, 16:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-11-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-09-01 to 2020-11-30$6.7mus-gaap:Revenues
Revenue12 months2019-12-01 to 2020-11-30$17.8mus-gaap:Revenues
Research and development12 months2019-12-01 to 2020-11-30$66.5mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2019-12-01 to 2020-11-30−$65.0mus-gaap:OperatingIncomeLoss
Income tax12 months2019-12-01 to 2020-11-30−$20.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-09-01 to 2020-11-30−$19.9mus-gaap:NetIncomeLoss
Net income12 months2019-12-01 to 2020-11-30−$43.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-09-01 to 2020-11-30−$0.51us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2019-12-01 to 2020-11-30−$2.76us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2019-12-01 to 2020-11-30−$80.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2019-12-01 to 2020-11-30$4.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-11-30$119.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-11-30$298.4mus-gaap:AssetsCurrent
Total assetsAt period end2020-11-30$396.3mus-gaap:Assets
Current liabilitiesAt period end2020-11-30$44.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-11-30$106.1mus-gaap:Liabilities
Shareholders' equityAt period end2020-11-30$290.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-21-006071. Last ingested by Listed: Nov 5, 2026, 13:59 ET. Listed shows no prices and gives no investment advice.